The protein corona protects against size- and dose-dependent toxicity of amorphous silica nanoparticles

被引:65
作者
Docter, Dominic [1 ]
Bantz, Christoph [2 ]
Westmeier, Dana [1 ]
Galla, Hajo J. [3 ]
Wang, Qiangbin [4 ]
Kirkpatrick, James C. [5 ]
Nielsen, Peter [6 ]
Maskos, Michael [2 ]
Stauber, Roland H. [1 ]
机构
[1] ENT Univ Med Ctr Mainz, D-55101 Mainz, Germany
[2] Fraunhofer ICT IMM, D-55129 Mainz, Germany
[3] Univ Munster, Inst Biochem, D-48149 Munster, Germany
[4] Chinese Acad Sci, Suzhou Inst Nanotech & Nanobion, Suzhou 215123, Peoples R China
[5] Univ Med Ctr, Inst Pathol, D-55101 Mainz, Germany
[6] Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Cell Biol, Hamburg, Germany
关键词
biobarrier; gastrointestinal tract; high-throughput profiling; nanomedicine; nanotoxicity; SURFACE-PROPERTIES; CELL; CYTOTOXICITY; NANOMATERIALS; INHIBITOR; APOPTOSIS; HEAD;
D O I
10.3762/bjnano.5.151
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Besides the lung and skin, the gastrointestinal (GI) tract is one of the main targets for accidental exposure or biomedical applications of nanoparticles (NP). Biological responses to NP, including nanotoxicology, are caused by the interaction of the NP with cellular membranes and/or cellular entry. Here, the physico-chemical characteristics of NP are widely discussed as critical determinants, albeit the exact mechanisms remain to be resolved. Moreover, proteins associate with NP in physiological fluids, forming the protein corona potentially transforming the biological identity of the particle and thus, adding an additional level of complexity for the bio-nano responses. Here, we employed amorphous silica nanoparticles (ASP) and epithelial GI tract Caco-2 cells as a model to study the biological impact of particle size as well as of the protein corona. Caco-2 or mucus-producing HT-29 cells were exposed to thoroughly characterized, negatively charged ASP of different size in the absence or presence of proteins. Comprehensive experimental approaches, such as quantifying cellular metabolic activity, microscopic observation of cell morphology, and high-throughput cell analysis revealed a dose-and time-dependent toxicity primarily upon exposure with ASP30 (empty set = 30 nm). Albeit smaller (ASP20, empty set = 20 nm) or larger particles (ASP100; empty set = 100 nm) showed a similar zeta potential, they both displayed only low toxicity. Importantly, the adverse effects triggered by ASP30/ASP30L were significantly ameliorated upon formation of the protein corona, which we found was efficiently established on all ASP studied. As a potential explanation, corona formation reduced ASP30 cellular uptake, which was however not significantly affected by ASP surface charge in our model. Collectively, our study uncovers an impact of ASP size as well as of the protein corona on cellular toxicity, which might be relevant for processes at the nano-bio interface in general.
引用
收藏
页码:1380 / 1392
页数:13
相关论文
共 56 条
[31]   Nanomaterial Toxicity Testing in the 21st Century: Use of a Predictive Toxicological Approach and High-Throughput Screening [J].
Nel, Andre ;
Xia, Tian ;
Meng, Huan ;
Wang, Xiang ;
Lin, Sijie ;
Ji, Zhaoxia ;
Zhang, Haiyuan .
ACCOUNTS OF CHEMICAL RESEARCH, 2013, 46 (03) :607-621
[32]  
Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]
[33]   Alterations in Mucus Barrier Function and Matrix Structure Induced by Guluronate Oligomers [J].
Nordgard, Catherine Taylor ;
Nonstad, Unni ;
Olderoy, Magnus O. ;
Espevik, Terje ;
Draget, Kurt I. .
BIOMACROMOLECULES, 2014, 15 (06) :2294-2300
[34]   Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology [J].
Oberdorster, G. .
JOURNAL OF INTERNAL MEDICINE, 2010, 267 (01) :89-105
[35]   On the role of surface composition and curvature on biointerface formation and colloidal stability of nanoparticles in a protein-rich model system [J].
Orts-Gil, Guillermo ;
Natte, Kishore ;
Thiermann, Raphael ;
Girod, Matthias ;
Rades, Steffi ;
Kalbe, Henryk ;
Thuenemann, Andreas F. ;
Maskos, Michael ;
Oesterle, Werner .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2013, 108 :110-119
[36]   Genotoxicity evaluation of amorphous silica nanoparticles of different sizes using the micronucleus and the plasmid lacZ gene mutation assay [J].
Park, Margriet V. D. Z. ;
Verharen, Henny W. ;
Zwart, Edwin ;
Hernandez, Lya G. ;
van Benthem, Jan ;
Elsaesser, Andreas ;
Barnes, Clifford ;
Mckerr, George ;
Howard, C. Vyvyan ;
Salvati, Anna ;
Lynch, Iseult ;
Dawson, Kenneth A. ;
de Jong, Wim H. .
NANOTOXICOLOGY, 2011, 5 (02) :168-181
[37]   Synthetic nanoparticle vaccines produced by layer-by-layer assembly of artificial biofilms induce potent protective T-cell and antibody responses in vivo [J].
Powell, Thomas J. ;
Palath, Naveen ;
DeRome, Mary E. ;
Tang, Jie ;
Jacobs, Andrea ;
Boyd, James G. .
VACCINE, 2011, 29 (03) :558-569
[38]   Nanomedicine-Challenge and Perspectives [J].
Riehemann, Kristina ;
Schneider, Stefan W. ;
Luger, Thomas A. ;
Godin, Biana ;
Ferrari, Mauro ;
Fuchs, Harald .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2009, 48 (05) :872-897
[39]   The Challenge To Relate the Physicochemical Properties of Colloidal Nanoparticles to Their Cytotoxicity [J].
Rivera-Gil, Pilar ;
Jimenez De Aberasturi, Dorleta ;
Wulf, Verena ;
Pelaz, Beatriz ;
Del Pino, Pablo ;
Zhao, Yuanyuan ;
De La Fuente, Jesus M. ;
Ruiz De Larramendi, Idoia ;
Rojo, Teofilo ;
Liang, Xing-Jie ;
Parak, Wolfgang J. .
ACCOUNTS OF CHEMICAL RESEARCH, 2013, 46 (03) :743-749
[40]   Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applications [J].
Rizzo, Larissa Y. ;
Theek, Benjamin ;
Storm, Gert ;
Kiessling, Fabian ;
Lammers, Twan .
CURRENT OPINION IN BIOTECHNOLOGY, 2013, 24 (06) :1159-1166